ArticleJournal of nanobiotechnology2025

CXCL12-targeting siRNA nanoparticles alleviate immunosuppression and inhibit tumor progression in esophageal squamous cell carcinoma.

Shuyao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.